Pat Cotroneo's Insider Trades & SAST Disclosures
Pat Cotroneo's most recent trade in FibroGen Inc was a trade of 2,141 Common Stock done at an average price of $12.4 . Disclosure was reported to the exchange on Sept. 7, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Pat Cotroneo.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroGen Inc | Pat Cotroneo | Executive Advisor & Former CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.41 per share. | 07 Sep 2021 | 2,141 | 274,536 (0%) | 0% | 12.4 | 26,570 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 25.62 per share. | 15 Jun 2021 | 4,053 | 276,677 (0%) | 0% | 25.6 | 103,838 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.90 per share. | 07 Jun 2021 | 2,141 | 280,730 (0%) | 0% | 22.9 | 49,029 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.37 per share. | 08 Mar 2021 | 5,657 | 282,187 (0%) | 0% | 33.4 | 188,774 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 41,700 | 41,700 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 21,700 | 287,844 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 43.60 per share. | 15 Dec 2020 | 3,068 | 266,144 (0%) | 0% | 43.6 | 133,765 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.99 per share. | 07 Dec 2020 | 3,014 | 269,212 (0%) | 0% | 42.0 | 126,558 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 43.63 per share. | 15 Sep 2020 | 3,070 | 272,226 (0%) | 0% | 43.6 | 133,944 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.16 per share. | 08 Sep 2020 | 3,014 | 275,296 (0%) | 0% | 42.2 | 127,070 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 50.91 per share. | 03 Sep 2020 | 15,004 | 278,310 (0%) | 0% | 50.9 | 763,854 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.40 per share. | 03 Sep 2020 | 8,671 | 293,314 (0%) | 0% | 25.4 | 220,243 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2020 | 8,671 | 41,579 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.39 per share. | 03 Sep 2020 | 5,696 | 284,643 (0%) | 0% | 19.4 | 110,445 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2020 | 5,696 | 0 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2020 | 637 | 4,618 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.66 per share. | 03 Sep 2020 | 637 | 278,947 (0%) | 0% | 29.7 | 18,893 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2020 | 22,554 | 9,446 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 07 Aug 2020 | 22,554 | 271,060 (0%) | 0% | 48 | 1,082,592 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.39 per share. | 07 Aug 2020 | 22,554 | 293,614 (0%) | 0% | 19.4 | 437,322 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.39 per share. | 07 Aug 2020 | 3,750 | 274,810 (0%) | 0% | 19.4 | 72,713 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2020 | 3,750 | 5,696 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2020 | 3,500 | 0 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 07 Aug 2020 | 3,500 | 278,310 (0%) | 0% | 18 | 63,000 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 39.68 per share. | 16 Jun 2020 | 3,928 | 271,060 (0%) | 0% | 39.7 | 155,863 | Common Stock |
| FibroGen Inc | Pat Cotroneo | SVP, Finance and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.61 per share. | 08 Jun 2020 | 2,156 | 274,988 (0%) | 0% | 33.6 | 72,463 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges